Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose Chemotherapy
暂无分享,去创建一个
R. Salazar | J. Tabernero | J. Cancelas | C. Pericay | R. Mesía | P. Maroto | A. López-pousa | J. Montesinos | C. Martínez | C. Sola | J. López-López | J. Brunet | L. Mendoza